X0202 SCHEDULE 13G 0002148726 XXXXXXXX LIVE Class A ordinary shares 07/27/2026 0001809616 Universe Pharmaceuticals INC G9442G138 265 Jingjiu Avenue Jinggangshan Economic and Technological Ji'an F4 343100 Rule 13d-1(c) Whitmore Limited D8 0.00 499424.00 0.00 499424.00 499424.00 N 9.97 CO The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Whitmore Limited, a company with limited liability formed in the British Virgin Islands. Whitmore Limited is wholly owned and controlled by Chengming Tang, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Chengming Tang F4 0.00 499424.00 0.00 499424.00 499424.00 N 9.97 IN The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Whitmore Limited, a company with limited liability formed in the British Virgin Islands. Whitmore Limited is wholly owned and controlled by Chengming Tang, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Universe Pharmaceuticals INC 265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi, CHINA, 343100 Whitmore Limited Chengming Tang Whitmore Limited: Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, British Virgin Islands Chengming Tang: Room 508, Block 20, Country Garden Kang Garden, Guangzhou, Guangdong Province 510000, People's Republic of China Whitmore Limited: British Virgin Islands Chengming Tang: People's Republic of China Y Whitmore Limited: 499,424.00 Chengming Tang: 499,424.00 Whitmore Limited: 9.97% Chengming Tang: 9.97% See Row 5 of the cover page for each Reporting Person. See Row 6 of the cover page for each Reporting Person. See Row 7 of the cover page for each Reporting Person. See Row 8 of the cover page for each Reporting Person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 99.1 - Joint Filing Agreement Whitmore Limited /s/ Chengming Tang 09/01/2026 Chengming Tang /s/ Chengming Tang 09/01/2026